Joint (JYNT) | Financial Analysis & Statements
The Joint Corp. Micro-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
15.2M
Gross Profit
12.3M
81.41%
Operating Income
743.9K
4.90%
Net Income
991.1K
6.53%
Balance Sheet Metrics
Total Assets
61.0M
Total Liabilities
45.9M
Shareholders Equity
15.1M
Debt to Equity
3.04
Cash Flow Metrics
Operating Cash Flow
94.4K
Free Cash Flow
2.5M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Joint Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 54.9M | 52.2M | 117.7M | 101.3M | 80.0M |
| Cost of Goods Sold | 11.2M | 11.5M | 10.5M | 9.2M | 7.7M |
| Gross Profit | 43.7M | 40.6M | 107.1M | 92.1M | 72.3M |
| Gross Margin % | 79.6% | 77.9% | 91.0% | 90.9% | 90.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 42.9M | 41.1M | 98.0M | 84.2M | 62.3M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 42.9M | 41.1M | 98.0M | 84.2M | 62.3M |
| Operating Income | -905.5K | -1.8M | 559.5K | 1.2M | 6.2M |
| Operating Margin % | -1.6% | -3.5% | 0.5% | 1.2% | 7.7% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | 676.0K | 214.3K | 1.1M | -543.3K | -96.7K |
| Pre-tax Income | -229.5K | -1.6M | 1.6M | 695.2K | 6.1M |
| Income Tax | 38.7K | 5.6K | 11.4M | 68.4K | -1.5M |
| Effective Tax Rate % | 0.0% | 0.0% | 695.1% | 9.8% | -24.9% |
| Net Income | 2.9M | -5.8M | -9.8M | 626.7K | 7.6M |
| Net Margin % | 5.3% | -11.1% | -8.3% | 0.6% | 9.5% |
| Key Metrics | |||||
| EBITDA | 816.1K | 3.0M | 11.8M | 8.3M | 10.1M |
| EPS (Basic) | $0.19 | $-0.57 | $-0.66 | $0.08 | $0.50 |
| EPS (Diluted) | $0.19 | $-0.57 | $-0.66 | $0.08 | $0.48 |
| Basic Shares Outstanding | 15134215 | 14919091 | 14688115 | 14488314 | 14319448 |
| Diluted Shares Outstanding | 15134215 | 14919091 | 14688115 | 14488314 | 14319448 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Joint Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 23.6M | 25.1M | 18.2M | 9.7M | 19.5M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 2.8M | 2.6M | 3.7M | 3.9M | 3.7M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 1.7M | 1.8M | 2.4M | 2.1M | 2.3M |
| Total Current Assets | 52.1M | 74.6M | 44.3M | 17.6M | 26.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.6M | 555.5K | 12.6M | 20.7M | 18.7M |
| Goodwill | - | - | 19.7M | 27.9M | 14.9M |
| Intangible Assets | - | - | 5.0M | 10.9M | 4.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 4.1M | 4.8M | 7.0M | 18.4M | 17.6M |
| Total Non-Current Assets | 8.9M | 8.6M | 42.8M | 75.9M | 60.2M |
| Total Assets | 61.0M | 83.2M | 87.2M | 93.5M | 87.1M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.6M | 1.8M | 1.6M | 3.0M | 1.7M |
| Short-term Debt | 194.2K | 483.3K | 3.8M | 5.3M | 4.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 22.7M | 38.9M | 15.4M | 1.4M | 925.7K |
| Total Current Liabilities | 32.8M | 49.0M | 33.6M | 23.2M | 21.4M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.8M | 311.7K | 13.0M | 20.7M | 19.0M |
| Deferred Tax Liabilities | - | 0 | - | - | - |
| Other Non-Current Liabilities | - | - | 1.2M | 1.3M | 895.7K |
| Total Non-Current Liabilities | 13.1M | 13.4M | 28.8M | 37.7M | 35.3M |
| Total Liabilities | 45.9M | 62.5M | 62.4M | 60.9M | 56.8M |
| Equity | |||||
| Common Stock | 15.5K | 15.2K | 14.8K | 14.6K | 14.4K |
| Retained Earnings | -24.8M | -27.7M | -21.9M | -12.2M | -12.8M |
| Treasury Stock | 12.2M | 870.1K | 860.5K | 856.6K | 850.8K |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 15.1M | 20.7M | 24.8M | 32.6M | 30.3M |
| Key Metrics | |||||
| Total Debt | 2.0M | 795.0K | 16.7M | 26.1M | 23.6M |
| Working Capital | 19.3M | 25.5M | 10.8M | -5.6M | 5.5M |
Balance Sheet Composition
Joint Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.9M | -5.8M | -9.8M | 626.7K | 7.6M |
| Depreciation & Amortization | 1.7M | 4.7M | 8.6M | 6.6M | 3.9M |
| Stock-Based Compensation | 1.3M | 1.7M | 1.7M | 1.3M | 1.1M |
| Working Capital Changes | -5.7M | -6.0M | -1.1M | 2.8M | 1.9M |
| Operating Cash Flow | -21.8K | -5.7M | 10.1M | 10.9M | 12.6M |
| Investing Activities | |||||
| Capital Expenditures | -1.5M | -1.2M | -5.0M | -5.9M | -7.0M |
| Acquisitions | 7.8M | 554.1K | -1.2M | -12.0M | -5.8M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 6.3M | -631.5K | -6.2M | -17.9M | -12.8M |
| Financing Activities | |||||
| Share Repurchases | -11.3M | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | -4.4K | -2.0M | -24.4K | -49.9K | -2.8M |
| Financing Cash Flow | -11.3M | -2.0M | -24.4K | -49.9K | -5.5M |
| Free Cash Flow | 334.7K | 8.2M | 9.7M | 2.3M | 6.9M |
| Net Change in Cash | -5.1M | -8.4M | 3.9M | -7.1M | -5.7M |
Cash Flow Trend
Joint Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
66.00
Forward P/E
38.13
Price to Book
8.06
Price to Sales
2.24
PEG Ratio
-0.48
Profitability Ratios
Profit Margin
5.30%
Operating Margin
4.25%
Return on Equity
-1.50%
Return on Assets
-0.79%
Financial Health
Current Ratio
1.59
Debt to Equity
13.33
Beta
1.23
Per Share Data
EPS (TTM)
$-0.02
Book Value per Share
$1.06
Revenue per Share
$3.63
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| JYNT | 126.0M | 66.00 | 8.06 | -1.50% | 5.30% | 13.33 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| AirSculpt | 172.1M | 197.00 | 1.79 | -14.06% | -7.69% | 95.28 |
| Kindly MD | 150.2M | -17.25 | 98.19 | -763.28% | -177.03% | 43.58 |
| Kindly MD | 112.4M | - | 73.41 | -763.28% | -177.03% | 43.58 |
Financial data is updated regularly. All figures are in the company's reporting currency.






